SYMBIOTEC PHARMALAB LTD Share Price

SYMBIOTEC PHARMALAB LTD Share Price

NSE: SYMBIOTEC
|
Pharmaceuticals

₹ 1,087.50

-₹6.30 (-0.58%)
1D
Last updated 09 Oct, 2026, 15:55 IST

SYMBIOTEC PHARMALAB LTD Share Price Today

As of 11 Oct 2026, SYMBIOTEC PHARMALAB LTD share price is ₹1,087.50. The stock opened at ₹1,081.00, compared to its previous close of ₹1,093.80. During today's trading session, SYMBIOTEC PHARMALAB LTD share price moved in the range of ₹1,078.10 to ₹1,112.50, with an average price of ₹1,095.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹934.20 and a high of ₹1,246.00. On the performance front, SYMBIOTEC PHARMALAB LTD share price has declined by 0.93% over the last six months and is down 0.93% on a year-on-year basis.

₹1,078.10
0.58% down today
₹1,112.50
1D LOW
1D HIGH

SYMBIOTEC PHARMALAB LTD Returns Calculator

Volume
4,02,278
Average traded price
₹1,091.91
Last traded time
03:55:57 09 Oct
Last traded quantity
10
Circuit
L
H
₹870.00
₹1,305.00
52-week
L
H
₹934.20
₹1,246.00
Mkt Cap Cr
6,990.10
P/E
0.0
P/B
0.0
ROA
7.01%
ROE
11.19%
ROCE
12.2%
Quick Ratio
0.47
EV/EBITDA
0.0
Based on fundamentals, this stock's
Step 3 of 5
Performance
Neutral
Symbiotec Pharma performance is moderate compared to markets
Step 3 of 5
Valuation
Fairly Valued
Symbiotec Pharma appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
Symbiotec Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,21,539.1634.795.0411.19%13.74%17.33%2.3121.42
Divis Laboratories2,47,576.0084.6414.7714.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.2221.084.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,11,231.6524.224.18.57%18.59%17.35%0.9114.87
Laurus Labs1,09,796.85100.720.7210.38%16.77%16.14%0.6853.86
Cipla1,05,289.7831.373.067.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories99,752.6431.332.625.48%11.07%12.54%1.3515.86
Mankind Pharma97,850.3847.326.07.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,014.4726.152.566.34%9.25%11.76%1.1512.47
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About SYMBIOTEC PHARMALAB LTD

SYMBIOTEC PHARMALAB LTD Share Price
ISIN
INE899I01028
Sector Market Cap
₹ 6,990.10 Cr

SYMBIOTEC PHARMALAB LTD Financial Highlights

  • Revenue: SYMBIOTEC PHARMALAB LTD reported revenue of ₹872.26 crore in FY26 vs ₹755.98 crore in FY25. It showed an increase of 15.38% on a yearly basis.
  • Operating Profit: SYMBIOTEC PHARMALAB LTD reported an operating profit of ₹153.36 crore in FY26 vs ₹146.98 crore in FY25. It showed an increase of 4.34% on a year-on-year basis.
  • Net Profit: SYMBIOTEC PHARMALAB LTD reported a net profit of ₹109.90 crore in FY26 vs ₹96.79 crore in FY25. It showed an increase of 13.54% on a yearly basis.

SYMBIOTEC PHARMALAB LTD Quarterly Result Highlights

  • SYMBIOTEC PHARMALAB LTD reported revenue of ₹218.49 crore in Jun 2026, compared with ₹245.41 crore in Mar 2026, representing a decrease of 10.97% on a quarter-on-quarter (QoQ) basis.
  • SYMBIOTEC PHARMALAB LTD reported an operating profit of ₹17.53 crore in Jun 2026, compared with ₹35.25 crore in Mar 2026, representing a decrease of 50.27% on a quarter-on-quarter (QoQ) basis.
  • SYMBIOTEC PHARMALAB LTD reported a profit of ₹14.06 crore in Jun 2026, compared with ₹27.53 crore in Mar 2026, reflecting a decrease of 48.93% on a QoQ basis.
  • The earnings per share (EPS) of SYMBIOTEC PHARMALAB LTD stood at ₹19.10 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
33.28%
FII
21.08%
Other DII
21.98%
Retail and other
18.12%
Mutual funds
5.54%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Aug 202621.08%
1 day
-0.58%
1 week
-9.22%
1 month
-4.08%
1 year
-0.93%
3 years
-0.93%
5 years
-0.93%
Day
Open / Close
Change %
09 Oct 26
₹1,081.00 / ₹1,087.50
-0.58%
08 Oct 26
₹1,130.00 / ₹1,093.80
-3.68%
07 Oct 26
₹1,149.40 / ₹1,135.60
-1.21%
06 Oct 26
₹1,168.90 / ₹1,149.50
-1.73%
Show more

SYMBIOTEC PHARMALAB LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹869.15₹751.55₹716.25₹566.51
Other Income₹3.11₹4.43₹7.09₹6.46
Total Revenue₹872.26₹755.98₹723.33₹572.97
Total Expenses₹709.90₹608.85₹590.99₹533.63
Profit Before Tax₹153.36₹147.13₹132.35₹39.34
Tax₹43.46₹50.19₹30.93₹14.78
Profit After Tax₹109.90₹96.94₹101.42₹24.56
EPS - Basic₹19.10₹88.50₹91.49₹21.48
EPS - Diluted₹19.00₹88.50₹91.49₹21.48

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹153.36₹146.98₹132.35₹39.34
Income before WC changes₹238.78₹208.87₹172.11₹73.21
Change in Assets-₹34.80₹2.36-₹122.13₹20.10
Change in Liabilities₹32.32-₹129.15₹171.80-₹6.07
Change in WC-₹2.47-₹126.79₹49.67₹14.03
Cash flow from Operations₹174.59₹47.26₹187.50₹69.24
Cash flow from Investing-₹226.93-₹306.52-₹206.41-₹219.99
Cash flow from Financing₹35.99₹278.16₹21.85₹146.14
Total Cash Flow-₹16.35₹18.90₹2.94-₹4.61
Cash (Start of the year)₹26.39₹7.50₹4.55₹9.16
Cash (End of the year)₹10.04₹26.39₹7.50₹4.55

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,295.25₹1,086.79₹786.58₹589.82
Current Assets₹485.54₹492.86₹508.21₹400.17
Total Assets₹1,780.79₹1,579.65₹1,294.79₹989.99
Current Liabilities₹527.57₹472.60₹351.21₹228.07
Net Current Asset-₹42.02₹20.26₹157.00₹172.10
Non-Current Liabilities₹103.64₹292.35₹228.73₹140.48
Equity Capital₹1,149.59₹814.71₹714.84₹621.44
Total Equity & Liabilities₹1,780.79₹1,579.65₹1,294.79₹989.99

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹756.68₹673.61₹563.59₹633.85
Other Income₹32.00₹19.76₹12.37₹5.65
Total Revenue₹788.69₹693.37₹575.96₹639.50
Total Expenses₹592.66₹575.47₹519.16₹556.72
Profit Before Tax₹196.02₹117.90-₹7.78₹82.77
Tax₹50.19₹28.95₹14.88₹21.04
Profit After Tax₹145.83₹88.95-₹22.66₹61.73
EPS - Basic₹133.35₹81.33-₹20.72₹56.45
EPS - Diluted₹133.35₹81.33-₹20.72₹56.45

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹196.02₹117.90-₹7.78₹82.77
Income before WC changes₹225.76₹144.09₹83.38₹105.85
Change in Assets₹36.48-₹106.61₹26.35-₹38.27
Change in Liabilities-₹144.12₹145.07-₹0.56-₹20.63
Change in WC-₹107.64₹38.46₹25.80-₹58.89
Cash flow from Operations₹83.29₹147.46₹93.35₹23.62
Cash flow from Investing-₹291.79-₹80.80-₹132.50-₹33.94
Cash flow from Financing₹224.81-₹62.98₹36.53₹14.73
Total Cash Flow₹16.31₹3.67-₹2.62₹4.41
Cash (Start of the year)₹6.20₹2.53₹5.15₹0.74
Cash (End of the year)₹22.51₹6.20₹2.53₹5.15

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹869.80₹594.93₹528.49₹478.86
Current Assets₹479.23₹498.29₹386.62₹415.62
Total Assets₹1,349.04₹1,093.22₹915.12₹894.48
Current Liabilities₹346.32₹298.66₹214.19₹172.15
Net Current Asset₹132.92₹199.63₹172.43₹243.47
Non-Current Liabilities₹91.93₹33.43₹28.12₹27.15
Equity Capital₹910.79₹761.14₹672.81₹695.18
Total Equity & Liabilities₹1,349.04₹1,093.22₹915.12₹894.48
* All values are in INR Crore
Qty
Bid
235
1087.5
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 235
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
3
Bullish
0
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
25.01
Bearish
ATR (14)
68.47
Neutral
STOCH(9,6)
35.31
Neutral
ADX(9)
32.69
Bearish
ROC(12)
-2.98
Bearish
WillR(14)
-60.84
Neutral
Period
Simple value
Exponential vaue
5D
1127.22
1114.7
10D
1121.42
1115.56
20D
1105.66
1156.75
50D
1103.16
0
100D
1103.16
0
Volume trend — traded volume by day
9 Oct4L
8 Oct6L
7 Oct4L
6 Oct6L
5 Oct7L
Average5L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SYMBIOTEC PHARMALAB LTD Share Price
SYMBIOTEC PHARMALAB LTD
Pharmaceuticals
Add Stock
Add Another

SYMBIOTEC PHARMALAB LTD Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.